The Accelerated Phase of Chediak-Higashi Syndrome: The Importance of Hematological Evaluation
Journal Title: Turkish Journal of Hematology - Year 2013, Vol 30, Issue 1
Abstract
Chediak-Higashi syndrome is a rare autosomal recessive disease that was first described in 1943 by Bequez-Cesar in 3 siblings that bore the primary clinical features. In 1952 Chediak (a Cuban hematologist) and in 1954 Higashi (a Japanese pediatrician) described a series of cases characterized by misdistribution of myeloperoxidase in the patients’ neutrophilic granules [1,2].
Authors and Affiliations
Shreekant Bharti, Prateek Bhatia, Deepak Bansal, Neelam Varma
Keywords
Related Articles
- EP ID EP163412
- DOI 10.4274/tjh.2012.0027
- Views 81
- Downloads 0
Lymphoma Associated with Sjögren’s Syndrome
Karbamazepine Bağlı Kırmızı Kan Hücresi Aplazisi: Bir Olgu Sunumu
Gonadotoxic Effects of Nilotinib in Chronic Myeloid Leukemia Treatment Dose in a Mouse Model
Objective: Tyrosine kinase inhibitors may have deleterious effects on spermatogenesis or folliculogenesis, resulting in male or female subfertility. The aim of this study is to determine the effect of nilotinib, which is...
A Rare Complication of Congenital Afibrinogenemia: Bone Cysts
A Rare Complication of Congenital Afibrinogenemia: Bone Cysts
Multi Drug Rezistans Protein 1 ile Survi Arasındaki İlişki